Curaleaf Holdings, Inc. is set to announce its latest quarterly earnings on Monday, May 4th, with a consensus estimate of -0.08 EPS.
In the current trading session, Curaleaf Holdings, Inc. (CURLF) is priced at $3.39, showing a decrease of -1.34% from the previous close. Trading volume is at $41,885, representing a 3.58% change compared to the average.
The company's most recent earnings report, released on Wednesday, February 25th, indicated an EPS of -0.05, slightly better than the consensus estimate of -0.08.
Curaleaf reported a net change in cash of -$6.00 million, with operating cash flow at $43 million and free cash flow at $27.24 million.
The company generated $338.19 million in revenue, resulting in a gross profit of $128.35 million. Operating income stood at $2.96 million, while net income was -$60.74 million, translating to an EPS of -7.87 cents.
Key ratios include a quick ratio of 1.52, gross profit margin of 37.95%, and a debt ratio of 36.45.
Curaleaf's total assets amount to $2.84 billion, with total liabilities at $2 billion, and net debt standing at $933.83 million.
This report provides insights into Curaleaf Holdings, Inc.'s financial performance, highlighting key metrics and trends for investors to consider.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of June 16, 2022, it operated 134 dispensaries and 26 cultivation sites in 22 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.